http://www.akceatx.com
Akcea Therapeutics, Inc. Company Intro
Our Commitment At Akcea, we’re on a mission to transform the treatment of unaddressed or under-addressed serious and rare diseases with leading-edge, RNA-targeted medicines. Whether you’re a patient living with a serious condition, or a physician whose patient desperately needs a therapy, we know you’re counting on us, and it fuels our unwavering commitment to … Continue reading "Home"
Industry
Healthcare
Akcea Therapeutics, Inc. Headquaters
22 Boston Wharf Road
Boston,02210
United States
Akcea Therapeutics, Inc. Share price
26 Oct 2020 01:03 GMT
$18.15
-0.02 (-0.11 %)
Akcea Therapeutics, Inc. Market cap
$1.846 B
WMC RANKING
2020
Akcea Therapeutics, Inc. # 19
BiotechnologyLatest Akcea Therapeutics, Inc. News
25 Oct 2020
Thermal Conductivity Measurement Market Size, Share ...
... Growth, Demand and Future Potential of Industry 2027 → Hypertriglyceridemia Treatment Market By Top Vendors – Acasti Pharma Inc, Akcea Therapeutics ...
25 Oct 2020
Hypertriglyceridemia Treatment Market By Top Vendors ...
Acasti Pharma Inc, Akcea Therapeutics Inc, Allergan Plc, Alnylam Pharmaceuticals Inc, Arisaph Pharmaceuticals Inc, AstraZeneca Plc, BASF SE, Cardax Inc, ...
26 Oct 2020
Therapy Market Research Provides an In-Depth Analysis on the Future Growth Prospects and Industry Trends Adopted by the Competitors | (2020-2027)
Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Novartis ... (US), Jazz Pharmaceuticals, Inc. (Ireland), and Akcea Therapeutics Others.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Akcea Therapeutics, Inc. | 6.08 | 2.15 | 5.77 | 0 | 0 | 0 | 6.02 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.26 | 100 | 18 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 25 | 0 | 0 | 98.33 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.80 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 92.34 |
Akcea Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Akcea Therapeutics, Inc. | $336,555 | $365,071 | $-41,519 | $1.846B | 19 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.228B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $54.719B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.699B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.79B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Akcea Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Akcea Therapeutics, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
